| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Republic of Korea | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | China | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Mexico | 2 | |
| #6 | Russian Federation | 2 | |
| #7 | Taiwan | 2 | |
| #8 | Brazil | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hong Hye Suk | 8 |
| #2 | Lee Tae Won | 7 |
| #3 | Lee Jae Won | 7 |
| #4 | Jun Hun | 7 |
| #5 | Park Cheol Won | 6 |
| #6 | Lee Sun Young | 6 |
| #7 | Ha Song Yi | 5 |
| #8 | Kim Nam Hyuck | 4 |
| #9 | Lee Yoon Jung | 4 |
| #10 | Park Se Hong | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021069944A1 | Pharmaceutical composition comprising mirabegron and process for manufacturing the same | |
| KR20190139601A | Combination formulation comprising bazedoxifene and vitamin D | |
| KR20180120309A | A Complex Formulation Comprising HMG-CoA Reductase Inhibitor and Calcium Channel Blocker | |
| KR101774690B1 | Pharmaceutical combination comprising raloxifene and vitamin D | |
| KR101612197B1 | A stabilized tablet comprising bupropion hydrochloride and a preparation method thereof |